Cargando…

Management of recurrent or metastatic thyroid cancer

Recently, vascular endothelial growth factor receptor (VEGFR)-targeted tyrosine kinase inhibitors (TKIs) have become available for the treatment of recurrent or metastatic thyroid cancer. However, a number of clinical challenges that impact the use of VEGFR-targeted TKI in daily clinical practice ha...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tahara, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922569/ https://www.ncbi.nlm.nih.gov/pubmed/29713501 http://dx.doi.org/10.1136/esmoopen-2018-000359

Ejemplares similares

Management of VEGFR-Targeted TKI for Thyroid Cancer
por: Enokida, Tomohiro, et al.
Publicado: (2021)

Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
por: Tahara, Makoto, et al.
Publicado: (2021)

Optimal use of lenvatinib in the treatment of advanced thyroid cancer
por: Takahashi, Shunji, et al.
Publicado: (2017)

Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer
por: Kim, Jinyoung, et al.
Publicado: (2021)

Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan
por: Tahara, Makoto, et al.
Publicado: (2020)

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Argiris, Athanassios, et al.
Publicado: (2017)

Management of metastatic thyroid cancer in pregnancy: risk and uncertainty
por: Rowe, Christopher W, et al.
Publicado: (2016)

Impact of outpatient pharmacy interventions on management of thyroid patients receiving lenvatinib
por: Suzuki, Shinya, et al.
Publicado: (2020)

Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
por: Ueda, Yuri, et al.
Publicado: (2020)

Radiofrequency Ablation of Recurrent Metastatic Papillary Thyroid Cancer to a Lymph Node
por: Ahmad, Shahzad, et al.
Publicado: (2022)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
por: Barbosa, Mayara Peres, et al.
Publicado: (2017)

Radiofrequency ablation of recurrent thyroid cancers: anatomy-based management
por: Lee, Min Kyoung, et al.
Publicado: (2022)

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions
por: Guigay, Joël, et al.
Publicado: (2019)

Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
por: Takahashi, Shunji, et al.
Publicado: (2020)

Metastatic papillary thyroid cancer presenting with a recurrent necrotic cystic cervical lymph node
por: Clark, Alexa, et al.
Publicado: (2019)

Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
por: Tumino, Dario, et al.
Publicado: (2017)

Individualized Prediction Of Metastatic Involvement Of Lymph Nodes Posterior To The Right Recurrent Laryngeal Nerve In Papillary Thyroid Carcinoma
por: Zhu, Jiang, et al.
Publicado: (2019)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018)

Intraoperative Management of the Recurrent Laryngeal Nerve Transected or Invaded by Thyroid Cancer
por: Masuoka, Hiroo, et al.
Publicado: (2022)

TEGAFIRI is an effective alternative regimen for the management of recurrent or metastatic colorectal cancer
por: HSU, TZU-CHI
Publicado: (2015)

SUN-489 MetastaticThyroidCancer
por: Vásquez, Romyna La Rosa
Publicado: (2020)

Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma
por: Xu, Melody J., et al.
Publicado: (2018)

Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes
por: Xu, Siyuan, et al.
Publicado: (2021)

Clinicopathological features of recurrent papillary thyroid cancer
por: Zhu, Jian, et al.
Publicado: (2015)

First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
por: Takahashi, Shunji, et al.
Publicado: (2022)

Recurrent follicular thyroid carcinoma metastatic to axillary lymph nodes mimicking pulmonary adenocarcinoma
por: Kim, Stephanie J, et al.
Publicado: (2021)

Optimal Management of the Unilateral Recurrent Laryngeal Nerve Involvement in Patients with Thyroid Cancer
por: Miyamaru, Satoru, et al.
Publicado: (2021)

Recurrence after Thyroid Operations
por: Beebe, S. P.
Publicado: (1917)

Platinum-based Chemotherapy Plus Cetuximab for the First-line Treatment of Japanese Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of a Phase II Trial
por: Yoshino, Takayuki, et al.
Publicado: (2013)

Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
por: Ha, Le Ngoc, et al.
Publicado: (2021)

Relationship Between MUC4 Variants and Metastatic Recurrence in Colorectal Cancer
por: Liu, Jieqiong, et al.
Publicado: (2023)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Endometrioid Adenocarcinoma Metastatic to the Thyroid, Presenting Like Anaplastic Thyroid Cancer
por: Pollak, Natasha, et al.
Publicado: (2011)

Thyroid crisis caused by metastatic thyroid cancer: an autopsy case report
por: Takedani, Kai, et al.
Publicado: (2021)

Metastatic Lymph Node Ratio of Central Neck Compartment Has Predictive Values for Locoregional Recurrence in Papillary Thyroid Microcarcinoma
por: Choi, Sung Yong, et al.
Publicado: (2016)

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
por: Lee, Myung-Chul, et al.
Publicado: (2019)

Metastatic mesothelioma to the thyroid
por: Rao, Sarika N., et al.
Publicado: (2014)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Sarcoidosis mimicking metastatic papillary thyroid cancer
por: Salih, Abdulwahid M., et al.
Publicado: (2015)

Metastatic colorectal cancer to a primary thyroid cancer
por: Cherk, Martin H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kgt0bvtljmbsvk5u0etemigdfi